Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer
Angelo E Volandes, Michael K Paasche-Orlow, Susan L Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Communications
|
March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology
|
June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
Andrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
June 5, 2012
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S Panageas, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
July 6, 2014
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
Katherine S Panageas, Anne S Reiner, Fabio M Iwamoto, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer
Angelo E Volandes, Michael K Paasche-Orlow, Susan L Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Nature Communications
|
March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Neuro-Oncology
|
June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
Andrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
June 5, 2012
Initial treatment patterns over time for anaplastic oligodendroglial tumors
Katherine S Panageas, Fabio M Iwamoto, Timothy F Cloughesy, et al.
Neuro-Oncology
|
July 6, 2014
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
Katherine S Panageas, Anne S Reiner, Fabio M Iwamoto, et al.
Page
of 3